Skip to main content
VCbacked
Log inGet Started

Dancann Pharma

Ansager, Denmark

Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.

$315K raised
Jul 2025
Post-IPO Debt
BiotechnologyManufacturingMedicalPharmaceuticalTherapeutics

Top Investors

Nordic Growth

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dancann Pharma

How much funding has Dancann Pharma raised?
Dancann Pharma has raised $315K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in July 2025.
Who are Dancann Pharma's investors?
Dancann Pharma's investors include Nordic Growth.
Where is Dancann Pharma headquartered?
Dancann Pharma is headquartered in Ansager, Denmark.
What does Dancann Pharma do?
Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.
What stage is Dancann Pharma at?
Dancann Pharma is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dancann Pharma — Funding & Investors." VCBacked, July 9, 2025, https://www.vcbacked.co/company/dancann-pharma. Accessed July 3, 2026.
APA
VCBacked. (2025). Dancann Pharma — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/dancann-pharma
Wikipedia (cite web)
{{cite web |title=Dancann Pharma — Funding & Investors |url=https://www.vcbacked.co/company/dancann-pharma |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K